- Supported exchanges /
- AU /
- BIT.AU
Biotron Ltd (BIT AU) stock market data APIs
A$0.019
-0(-0%)
as of September 16, 2024
Price chart is built with Anychart
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. The company was incorporated in 1999 and is based in Sydney, Australia.
Biotron Ltd Financial Data Overview
| 0.023 | |
| 0.019 | |
| - | |
| 0.023 | |
| 0.019 | |
| 0.016-0.125 | |
| 18 046 K | |
| 902 M | |
| 1 645 K | |
| -0.611 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'BIT',
Type:
'Common Stock',
Name:
'Biotron Ltd',
Exchange:
'AU',
CurrencyCode:
'AUD',
CurrencyName:
'Australian Dollar',
CurrencySymbol:
'A$',
CountryName:
'Australia',
CountryISO:
'AU',
OpenFigi:
'BBG000BBLGK1',
ISIN:
'AU000000BIT4',
CIK:
NULL,
EmployerIdNumber:
'',
FiscalYearEnd:
'June',
IPODate:
NULL,
InternationalDomestic:
'International',
Sector:
'Healthcare',
Industry:
'Biotechnology',
}
Biotron Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 1 645 K
- EBITDA -3 504 489
- Earnings Per Share 0
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Biotron Ltd Earnings via APIs
- Latest Release 2024-08-30
- EPS/Forecast NaN
Get Biotron Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
